Top Banner
MELAKU TEFERA
12

Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model

Jul 16, 2015

Download

Health & Medicine

Melaku Tefera
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model

MELAKU TEFERA

Page 2: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model

250TH

Recent outbreaks of West Nile Virus, Ebola, HemorrhagicFever, SARS, Monkey pox, Mad Cow Disease ,Avian Influenzaand Swine Influenza remind us that human and animal healthare intimately connected.

Page 3: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model

•Combined oral contraceptives •Progestin only pills •Inject able contraceptives •Hormonal implants •Tubal ligation and vasectomy •IUD (copper bearing and levonorgestrelIUS) •Fertility awareness methods and LAM •Barrier methods •Emergency contraception •New contraceptive technology

There

is no

safe co

ntracep

tion

Page 4: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model

• Macrophages of the uterus show a change in number and functional ability in the production of cytokines, reactive oxygen intermediates and bioactive lipids depending on the reproductive cycle

• Estrogen stimulates, whereas progesterone and testosterone suppress systemic and local production of immunoglobulins

Page 5: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model
Page 6: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model
Page 7: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model
Page 8: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model
Page 9: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model
Page 10: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model
Page 11: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model

• HIV patients should use the barrier method

• The demand for fertility control is expected to in developing countries alone is expected to grow to nearly 1 billion.

• The crucial issues in the future will therefore be aimed at optimizing the use of currently available methods and making them safe, effective and acceptable,

• In addition, there should be new developments in contraceptive technology.

• no completely novel breakthrough in this century at least.

Page 12: Modulation of TNFα and Nitric Oxide Production by Macrophages and Uterine Protein Expression in HIV Patients Taking Contraceptive Steroids: An Animal Model